[Form 4] Morningstar, Inc. Insider Trading Activity
Morningstar, Inc. (MORN) Executive Chairman Joseph D. Mansueto reported multiple sales of Common Stock under a Rule 10b5-1 trading plan adopted November 15, 2024. The Form 4 shows eight sale transactions executed August 15, 18 and 19, 2025, totaling 21,750 shares disposed of at reported weighted-average prices ranging approximately from $258.03 to $261.035. Following those transactions the filing shows the reporting person directly beneficially owns 9,340,231 shares and indirectly beneficially owns 5,336,106 shares held by grantor retained annuity trusts plus 150,000 shares held in trusts for the benefit of his children. The filing notes the sales were effected pursuant to the 10b5-1 plan and provides ranges of execution prices for each grouped trade.
Joseph D. Mansueto, Presidente Esecutivo di Morningstar, Inc. (MORN), ha comunicato più vendite di Azioni Ordinarie nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 15 novembre 2024. Il Modulo 4 riporta otto operazioni di vendita eseguite il 15, 18 e 19 agosto 2025, per un totale di 21.750 azioni cedute a prezzi medi ponderati indicati approssimativamente tra $258,03 e $261,035. Dopo tali transazioni la dichiarazione indica che la persona segnalante detiene direttamente in modo beneficiario 9.340.231 azioni e detiene indirettamente in modo beneficiario 5.336.106 azioni tramite grantor retained annuity trusts, oltre a 150.000 azioni in trust a beneficio dei suoi figli. La comunicazione precisa che le vendite sono state effettuate in base al piano 10b5-1 e fornisce gli intervalli dei prezzi di esecuzione per ciascun gruppo di operazioni.
Joseph D. Mansueto, Presidente Ejecutivo de Morningstar, Inc. (MORN), informó varias ventas de Acciones Comunes bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 15 de noviembre de 2024. El Formulario 4 muestra ocho transacciones de venta ejecutadas los días 15, 18 y 19 de agosto de 2025, por un total de 21.750 acciones vendidas a precios ponderados promedios reportados aproximadamente entre $258,03 y $261,035. Tras esas operaciones, la presentación indica que la persona informante posee de forma beneficiaria directa 9.340.231 acciones y de forma beneficiaria indirecta 5.336.106 acciones mantenidas en grantor retained annuity trusts, además de 150.000 acciones en fideicomisos para beneficio de sus hijos. La presentación señala que las ventas se efectuaron conforme al plan 10b5-1 y proporciona los rangos de precios de ejecución para cada grupo de operaciones.
Morningstar, Inc.(MORN)의 집행 의장 Joseph D. Mansueto가 2024년 11월 15일 채택된 Rule 10b5-1 거래 계획에 따라 보통주 여러 건을 매도했다고 보고했습니다. Form 4에는 2025년 8월 15일, 18일 및 19일에 실행된 8건의 매도 거래가 기재되어 있으며, 총 21,750주가 처분되었고 보고된 가중평균 가격은 대략 $258.03~$261.035 수준으로 표시되어 있습니다. 해당 거래 후 제출 자료에 따르면 보고인은 직접적으로 수익적으로 9,340,231주를 보유하고 있고, grantor retained annuity trusts를 통해 간접적으로 5,336,106주를 보유하며 자녀들을 위한 신탁에 150,000주를 보유하고 있습니다. 제출서류에는 매도는 10b5-1 계획에 따라 이루어졌으며 각 그룹 거래별 실행 가격 범위가 제시되어 있다고 명시되어 있습니다.
Joseph D. Mansueto, président exécutif de Morningstar, Inc. (MORN), a déclaré plusieurs ventes d'actions ordinaires dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 15 novembre 2024. Le formulaire 4 indique huit opérations de vente exécutées les 15, 18 et 19 août 2025, pour un total de 21 750 actions cédées à des prix moyens pondérés déclarés s'étendant approximativement de $258,03 à $261,035. À la suite de ces transactions, le dépôt indique que la personne déclarente détient directement à titre bénéficiaire 9 340 231 actions et de façon indirecte 5 336 106 actions détenues par des grantor retained annuity trusts, ainsi que 150 000 actions dans des trusts au bénéfice de ses enfants. Le dépôt précise que les ventes ont été effectuées en vertu du plan 10b5-1 et fournit les fourchettes de prix d'exécution pour chaque groupe de transactions.
Joseph D. Mansueto, Executive Chairman von Morningstar, Inc. (MORN), meldete mehrere Veräußerungen von Stammaktien im Rahmen eines am 15. November 2024 angenommenen Rule‑10b5‑1‑Handelsplans. Das Formular 4 weist acht Verkaufstransaktionen aus, die am 15., 18. und 19. August 2025 ausgeführt wurden und insgesamt 21.750 Aktien umfassen, die zu berichteten gewichteten Durchschnittspreisen von etwa $258,03 bis $261,035 veräußert wurden. Nach diesen Transaktionen gibt die Meldung an, dass die meldende Person direkt wirtschaftlich 9.340.231 Aktien besitzt und indirekt wirtschaftlich 5.336.106 Aktien hält, die in grantor retained annuity trusts verwaltet werden, sowie 150.000 Aktien in Trusts zugunsten seiner Kinder. Die Meldung weist darauf hin, dass die Verkäufe gemäß dem 10b5‑1‑Plan erfolgten und nennt für jede gruppierte Transaktion die Ausführungspreisspannen.
- Sales conducted under a Rule 10b5-1 trading plan, indicating pre-established execution and compliance with trading rules
- Detailed disclosure of post-transaction beneficial ownership including direct and indirect holdings and trustee roles
- Commitment to provide full execution details upon request, enhancing transparency about trade prices and quantities
- Executive Chairman sold 21,750 shares in August 2025, which is an insider disposition disclosed to the market
- Multiple sales over consecutive days may prompt investor questions about timing, though filed as 10b5-1 transactions
Insights
TL;DR Executive Chairman sold 21,750 shares under a pre-established 10b5-1 plan; remaining direct and indirect holdings remain substantial.
The Form 4 reveals structured disposition activity: eight sell transactions on August 15, 18 and 19, 2025, executed under a Rule 10b5-1 plan adopted November 15, 2024. The filings disclose weighted-average sale prices for grouped trades and state the precise post-transaction beneficial ownership totals: 9,340,231 shares directly and 5,486,106 shares indirectly via trusts. From an investor-analysis perspective, the record shows compliance with an established plan and transparency on execution price ranges, but it does not include any company performance data or reasons for the trust holdings and dispositions.
TL;DR Transactions were executed under a documented 10b5-1 plan and the filer disclosed trust ownership and trustee roles.
The report documents that the sales were made pursuant to a 10b5-1 trading plan, which provides an affirmative defense under Rule 10b5-1 when conditions are met. The filing also discloses the nature of indirect holdings: grantor retained annuity trusts for the reporting person and trusts for his children, and identifies trustees. The Form 4 includes undertaking language offering to supply detailed execution data upon request, supporting transparency. The filing does not allege any change in officer or director status.
Joseph D. Mansueto, Presidente Esecutivo di Morningstar, Inc. (MORN), ha comunicato più vendite di Azioni Ordinarie nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 15 novembre 2024. Il Modulo 4 riporta otto operazioni di vendita eseguite il 15, 18 e 19 agosto 2025, per un totale di 21.750 azioni cedute a prezzi medi ponderati indicati approssimativamente tra $258,03 e $261,035. Dopo tali transazioni la dichiarazione indica che la persona segnalante detiene direttamente in modo beneficiario 9.340.231 azioni e detiene indirettamente in modo beneficiario 5.336.106 azioni tramite grantor retained annuity trusts, oltre a 150.000 azioni in trust a beneficio dei suoi figli. La comunicazione precisa che le vendite sono state effettuate in base al piano 10b5-1 e fornisce gli intervalli dei prezzi di esecuzione per ciascun gruppo di operazioni.
Joseph D. Mansueto, Presidente Ejecutivo de Morningstar, Inc. (MORN), informó varias ventas de Acciones Comunes bajo un plan de negociación conforme a la Regla 10b5-1 adoptado el 15 de noviembre de 2024. El Formulario 4 muestra ocho transacciones de venta ejecutadas los días 15, 18 y 19 de agosto de 2025, por un total de 21.750 acciones vendidas a precios ponderados promedios reportados aproximadamente entre $258,03 y $261,035. Tras esas operaciones, la presentación indica que la persona informante posee de forma beneficiaria directa 9.340.231 acciones y de forma beneficiaria indirecta 5.336.106 acciones mantenidas en grantor retained annuity trusts, además de 150.000 acciones en fideicomisos para beneficio de sus hijos. La presentación señala que las ventas se efectuaron conforme al plan 10b5-1 y proporciona los rangos de precios de ejecución para cada grupo de operaciones.
Morningstar, Inc.(MORN)의 집행 의장 Joseph D. Mansueto가 2024년 11월 15일 채택된 Rule 10b5-1 거래 계획에 따라 보통주 여러 건을 매도했다고 보고했습니다. Form 4에는 2025년 8월 15일, 18일 및 19일에 실행된 8건의 매도 거래가 기재되어 있으며, 총 21,750주가 처분되었고 보고된 가중평균 가격은 대략 $258.03~$261.035 수준으로 표시되어 있습니다. 해당 거래 후 제출 자료에 따르면 보고인은 직접적으로 수익적으로 9,340,231주를 보유하고 있고, grantor retained annuity trusts를 통해 간접적으로 5,336,106주를 보유하며 자녀들을 위한 신탁에 150,000주를 보유하고 있습니다. 제출서류에는 매도는 10b5-1 계획에 따라 이루어졌으며 각 그룹 거래별 실행 가격 범위가 제시되어 있다고 명시되어 있습니다.
Joseph D. Mansueto, président exécutif de Morningstar, Inc. (MORN), a déclaré plusieurs ventes d'actions ordinaires dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté le 15 novembre 2024. Le formulaire 4 indique huit opérations de vente exécutées les 15, 18 et 19 août 2025, pour un total de 21 750 actions cédées à des prix moyens pondérés déclarés s'étendant approximativement de $258,03 à $261,035. À la suite de ces transactions, le dépôt indique que la personne déclarente détient directement à titre bénéficiaire 9 340 231 actions et de façon indirecte 5 336 106 actions détenues par des grantor retained annuity trusts, ainsi que 150 000 actions dans des trusts au bénéfice de ses enfants. Le dépôt précise que les ventes ont été effectuées en vertu du plan 10b5-1 et fournit les fourchettes de prix d'exécution pour chaque groupe de transactions.
Joseph D. Mansueto, Executive Chairman von Morningstar, Inc. (MORN), meldete mehrere Veräußerungen von Stammaktien im Rahmen eines am 15. November 2024 angenommenen Rule‑10b5‑1‑Handelsplans. Das Formular 4 weist acht Verkaufstransaktionen aus, die am 15., 18. und 19. August 2025 ausgeführt wurden und insgesamt 21.750 Aktien umfassen, die zu berichteten gewichteten Durchschnittspreisen von etwa $258,03 bis $261,035 veräußert wurden. Nach diesen Transaktionen gibt die Meldung an, dass die meldende Person direkt wirtschaftlich 9.340.231 Aktien besitzt und indirekt wirtschaftlich 5.336.106 Aktien hält, die in grantor retained annuity trusts verwaltet werden, sowie 150.000 Aktien in Trusts zugunsten seiner Kinder. Die Meldung weist darauf hin, dass die Verkäufe gemäß dem 10b5‑1‑Plan erfolgten und nennt für jede gruppierte Transaktion die Ausführungspreisspannen.